Publications

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

July 30, 2018

Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study

Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome

February 1, 2018

Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

January 6, 2018

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

January 6, 2018

Mycobacterial biomaterials and resources for researchers

January 6, 2018

Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop

January 6, 2018

Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium

May 17, 2018

New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing

This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches

March 14, 2018

Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin

August 3, 2018

Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development

February 28, 2018

Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices

Previous1617 18...35 Next